XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Stock-Based Compensation  
Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

 

​

​

​

​

​

​

Average

​

Aggregate

 

​

​

​

​

Weighted

​

Remaining

​

Intrinsic

 

​

​

​

​

Average

​

Contractual

​

Value

​

​

    

Options

    

Exercise Price

    

Term (in years)

    

(in millions)

 

Options outstanding at January 1, 2022

 

65,300,748

​

$

42.00

 

6.47

​

$

2,968.8

​

Options granted

 

532,721

​

 

85.92

​

​

​

​

​

​

Options exercised

 

(646,759)

​

 

30.24

​

​

​

​

​

​

Options forfeited

 

(136,140)

​

 

47.07

​

​

​

​

​

​

Options outstanding at March 31, 2022

 

65,050,570

​

$

42.46

 

6.27

​

$

2,145.0

​

Vested and non-vested options expected to vest at March 31, 2022

 

62,416,843

​

$

42.14

 

6.20

​

$

2,078.2

​

Exercisable options at March 31, 2022

 

33,332,906

​

$

35.41

 

4.98

​

$

1,331.2

​

Summary of status of non-vested options and changes during the year

​

​

​

​

​

​

​

​

​

    

​

    

Weighted

 

​

​

​

​

Average

​

​

​

​

​

Fair Value at 

​

​

​

Options

​

Grant Date

 

Non-vested options at January 1, 2022

 

31,380,283

​

$

8.34

​

Options granted

 

532,721

​

 

17.97

​

Options vested

 

(59,200)

​

 

10.69

​

Options forfeited

 

(136,140)

​

 

7.68

​

Non-vested options at March 31, 2022

 

31,717,664

​

$

8.50

​

Summary of activity in the option plans

​

​

​

​

​

​

​

​

​

 

Three Months Ended

​

​

March 31, 

​

​

2022

​

2021

Total intrinsic value of stock options exercised

​

$

34.3

​

$

28.9

Total fair value of stock options vested

​

 

0.6

​

 

0.4

Schedule of restricted share activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted Average

​

​

​

​

​

​

​

Remaining

​

​

​

Restricted

​

Fair Value at 

​

Amortization

​

​

  

Shares

 

Grant Date

 

Term (in years)

 

Restricted shares outstanding at January 1, 2022

 

21,061

​

$

66.92

​

0.38

​

Restricted shares granted

 

—

​

 

—

​

​

​

Restricted shares outstanding at March 31, 2022

 

21,061

​

$

66.92

 

0.13

​